Romina Nemecek1, Patrick Huber2, Sophie Schur3,4, Eva Katharina Masel4, Lukas Baumann5, Christoph Hoeller2, Herbert Watzke4, Michael Binder2. 1. Department of Dermatology, Medical University of Vienna, Vienna, Austria. romina.nemecek@gmx.at. 2. Department of Dermatology, Medical University of Vienna, Vienna, Austria. 3. Department of Internal Medicine, Hospital Sankt Josef, Vienna, Austria. 4. Department of Palliative Medicine, Medical University of Vienna, Vienna, Austria. 5. Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
Abstract
BACKGROUND: Studies have shown that initiating early palliative care of patients with end-stage cancer can improve their quality of life and decrease symptoms of depression. The challenge is to find an effective way to care for these patients while minimizing the burden on healthcare resources. Telemedicine can play a vital role in solving this problem. METHODS: A user-friendly telemedical device enabling patients encountering medical problems to send a direct request to a palliative care team was developed. A controlled feasibility study was conducted by assigning 15 patients with advanced cancer and their family caregivers to receive either standard palliative care or telemedically augmented palliative care. Th quality of life (QoL) was assessed using standardized validated questionnaires as well as frequency and duration of hospital admissions and user satisfaction. The primary goal of this study was to increase the QoL of patients and their family caregivers. The secondary goal of this study was to decrease the frequency and duration of hospital admissions. RESULTS: This study showed a good feasibility despite the low overall willingness to participate in a relatively "technical" trial. The hospital anxiety and depression scale (HADS) was significantly lower in the intervention group, suggesting an improved quality of life. Although a decrease in the number of hospital admissions could not be shown, the user satisfaction was very good. CONCLUSION: Telemedicine could be a useful tool to enhance the general well-being of palliative oncology patients. Now that the feasibility of this approach has been confirmed, larger studies are needed to verify its positive impact on the QoL.
BACKGROUND: Studies have shown that initiating early palliative care of patients with end-stage cancer can improve their quality of life and decrease symptoms of depression. The challenge is to find an effective way to care for these patients while minimizing the burden on healthcare resources. Telemedicine can play a vital role in solving this problem. METHODS: A user-friendly telemedical device enabling patients encountering medical problems to send a direct request to a palliative care team was developed. A controlled feasibility study was conducted by assigning 15 patients with advanced cancer and their family caregivers to receive either standard palliative care or telemedically augmented palliative care. Th quality of life (QoL) was assessed using standardized validated questionnaires as well as frequency and duration of hospital admissions and user satisfaction. The primary goal of this study was to increase the QoL of patients and their family caregivers. The secondary goal of this study was to decrease the frequency and duration of hospital admissions. RESULTS: This study showed a good feasibility despite the low overall willingness to participate in a relatively "technical" trial. The hospital anxiety and depression scale (HADS) was significantly lower in the intervention group, suggesting an improved quality of life. Although a decrease in the number of hospital admissions could not be shown, the user satisfaction was very good. CONCLUSION: Telemedicine could be a useful tool to enhance the general well-being of palliative oncology patients. Now that the feasibility of this approach has been confirmed, larger studies are needed to verify its positive impact on the QoL.
Entities:
Keywords:
Advanced cancer; Family caregivers; HADS; Quality of life; Supportive care; Teleoncology
Authors: Ralph Peter Braun; Jean L Vecchietti; Luc Thomas; Christa Prins; Lars E French; Aron J Gewirtzman; Jean-Hilaire Saurat; Denis Salomon Journal: Arch Dermatol Date: 2005-02
Authors: Sharon M Watanabe; Alysa Fairchild; Edith Pituskin; Patricia Borgersen; John Hanson; Konrad Fassbender Journal: Support Care Cancer Date: 2012-11-17 Impact factor: 3.603
Authors: Laurel L Northouse; Maria C Katapodi; Lixin Song; Lingling Zhang; Darlene W Mood Journal: CA Cancer J Clin Date: 2010-08-13 Impact factor: 508.702
Authors: David A Fleming; Vanessa B Sheppard; Patricia A Mangan; Kathryn L Taylor; Michelle Tallarico; Inez Adams; Jane Ingham Journal: J Pain Symptom Manage Date: 2006-05 Impact factor: 3.612
Authors: Young Sun Rhee; Young Ho Yun; Sohee Park; Dong Ok Shin; Kwang Mi Lee; Han Jin Yoo; Jeong Hwa Kim; Soon Ok Kim; Ran Lee; Youn Ok Lee; Nam Shin Kim Journal: J Clin Oncol Date: 2008-11-24 Impact factor: 44.544
Authors: Natasha Ansari; Christina M Wilson; Mallorie B Heneghan; Kathie Supiano; Kathi Mooney Journal: Support Care Cancer Date: 2022-04-12 Impact factor: 3.603
Authors: William Goodman; Anne-Marie Bagnall; Laura Ashley; Desiree Azizoddin; Felix Muehlensiepen; David Blum; Michael I Bennett; Matthew Allsop Journal: JMIR Cancer Date: 2022-02-17
Authors: Sonu Bhaskar; Sian Bradley; Vijay Kumar Chattu; Anil Adisesh; Alma Nurtazina; Saltanat Kyrykbayeva; Sateesh Sakhamuri; Sebastian Moguilner; Shawna Pandya; Starr Schroeder; Maciej Banach; Daniel Ray Journal: Front Public Health Date: 2020-09-07